Reginald Seeto - 02 Feb 2022 Form 4 Insider Report for CareDx, Inc. (CDNA)

Role
President and Chief Executive Officer, Director
Signature
/s/ Reginald Seeto
Issuer symbol
CDNA
Transactions as of
02 Feb 2022
Net transactions value
-$428,206
Form type
4
Filing time
04 Feb 2022, 16:47:44 UTC
Previous filing
03 Feb 2022
Next filing
10 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CDNA Common Stock Sale $131,258 -3,182 -2.4% $41.25 126,746 02 Feb 2022 Direct F1
transaction CDNA Common Stock Award $0 +73,350 +58% $0.000000 200,096 02 Feb 2022 Direct F2
transaction CDNA Common Stock Tax liability $95,711 -2,388 -1.2% $40.08 197,708 03 Feb 2022 Direct F3
transaction CDNA Common Stock Sale $201,237 -4,988 -2.5% $40.34 192,720 04 Feb 2022 Direct F1, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CDNA Employee Stock Option (right to buy) Award $0 +83,350 $0.000000 83,350 02 Feb 2022 Common Stock 83,350 $41.32 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
F2 The reported securities are represented by restricted stock units, 1/4th of which shall vest on February 2, 2023 and 1/4th of which shall vest on each anniversary thereafter.
F3 These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of restricted stock units.
F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.10 to $40.57, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price.
F5 1/4th of the shares subject to the option shall vest on February 2, 2023 and 1/48th of the shares subject to the option shall vest monthly thereafter.

Remarks:

President and Chief Executive Officer